News >

FDA Approves Gemtuzumab Ozogamicin for Newly Diagnosed CD33+ AML

Published: Friday, Sep 01, 2017

The FDA has approved gemtuzumab ozogamicin (Mylotarg) for the treatment of adults with newly diagnosed CD33-positive acute myeloid leukemia (AML).
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication